Hinge Health's Successful IPO Signals Potential Revival for Digital Health Sector

Hinge Health, a digital musculoskeletal care company, made a strong debut on the New York Stock Exchange, potentially paving the way for a resurgence in digital health initial public offerings (IPOs). The company's shares opened at $39.25 on Thursday, representing a 23% increase from its initial public offering price of $32 per share.
IPO Details and Market Impact
Hinge Health raised $437.3 million in its IPO, pricing at the top of its marketed range. The company sold 8.5 million shares, with an additional 5.1 million shares sold by existing shareholders, for a total of 13.7 million shares. This successful listing brought the company's market capitalization to over $3 billion.
The strong performance of Hinge Health's IPO is viewed as a positive signal for the digital health sector, which has seen limited public offerings in recent years. Aaron DeGagne, senior analyst for healthcare at PitchBook, commented, "As long as [the share price] stays flat, I think it's a win for the sector. I think at this point any listing is a win."
Hinge Health's Financial Performance and Business Model
Hinge Health has demonstrated impressive financial metrics, including an 80%-plus gross margin, 117% net dollar retention, and double-digit free cash flow. The company reported a net income of $17.1 million in the first quarter of 2025, a significant improvement from a net loss of $26.5 million during the same period in the previous year.
Founded in 2014, Hinge Health offers digital musculoskeletal care and physical therapy services, utilizing artificial intelligence-backed movement sensors and wearable devices. The company's technology aims to automate care delivery, reducing human clinician hours by approximately 95% in physical therapy.
Daniel Perez, co-founder and CEO of Hinge Health, emphasized the company's unique position in the market, stating, "What makes us different is our technology is automating care delivery itself. And that is a fundamental change between what's ever come before, and our metrics prove it."
Outlook for Digital Health IPOs
Hinge Health's successful public debut may encourage other digital health companies to consider going public. Omada Health, a chronic condition management company, has already filed for an IPO earlier this month. Other potential candidates for future IPOs include Sword Health, Spring Health, and Maven.
While the IPO market has faced challenges due to economic uncertainties and shifting government policies, Hinge Health's performance suggests that well-positioned companies with strong financials may find opportunities in the public markets. The digital health sector, which saw a surge in IPOs during 2020-2021, may be poised for a new wave of public offerings as companies seek to capitalize on the growing demand for technology-driven healthcare solutions.
References
- Hinge Health goes public in positive signal for digital health IPOs
The digital musculoskeletal care company opened at $39.25 per share Thursday, rising 23% above its public offering price.
- Hinge Health shares jump 17% in stock market debut, setting the stage for digital health IPO revival
Shares of Hinge Health jumped 22% above the initial public offering price in the company's NYSE debut on Thursday, bringing its market capitalization to more than $3 billion.
Explore Further
What are the backgrounds and roles of the executive team at Hinge Health?
How does Hinge Health's technology and business model compare to its competitors in the digital health sector?
What is the target market size for digital musculoskeletal care and how might it impact Hinge Health's growth?
What challenges might other digital health companies face when considering IPOs in the current market environment?
Who are the main competitors of Hinge Health in the digital health and musculoskeletal care space?